ROMAZA :A Phase I Trial of Romidepsin plus Azacitidine combination therapy in patients with Newly Diagnosed, Relapsed or Refractory Acute Myeloid Leukaemia Ineligible for Slavage Chemotherapy (ROMAZA)

Project Details

Short titleROMAZA :A Phase I Trial of Romidepsin plus Azacitidine combination therapy in patients with Newly Diagnosed, Relapsed or Refractory Acute Myeloid Leukaemia Ineligible for Slavage Chemotherapy (ROMAZA)
StatusActive
Effective start/end date12/09/1230/09/22

Funding

  • CELGENE INTERNATIONAL SARL